SCHEMBL3797899

SCHEMBL3797899

O=C(NC1CCN(C(C(=O)O)N2CCC(NC(=O)c3ccccc3-c3ccc(C(F)(F)F)cc3)CC2)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.53
▸ MTTP P55157 10/20 0.52
▸ CHRM2 P08172 1/20 0.52
▸ ADRA2A P08913 1/20 0.52
▸ ADORA3 P0DMS8 1/20 0.52
▸ CHRM1 P11229 1/20 0.52
▸ DRD1 P21728 1/20 0.52
▸ TBXA2R P21731 1/20 0.52
▸ PTGS1 P23219 1/20 0.52
▸ SLC6A2 P23975 1/20 0.52
▸ ADRA1A P35348 1/20 0.52
▸ OPRM1 P35372 1/20 0.52
▸ DRD3 P35462 1/20 0.52
▸ SLC6A3 Q01959 1/20 0.52
▸ KCNH2 Q12809 1/20 0.52
▸ MTR Q99707 1/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ LMNA P02545 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20074564 0.84 CHRNB2 (0.59) GAAMTTPCHRM2ADRA2AADORA3
SCHEMBL3731129 0.83 MTTP (0.59) GAAMTTPCHRM2ADRA2AADORA3
SCHEMBL3731091 0.82 DRD4 (0.68) MTTPCHRM2ADRA2AADORA3CHRM1
SCHEMBL3730705 0.81 GAA (0.59) GAAMTTPCHRM2ADRA2AADORA3
SCHEMBL13351375 0.80 MTTP (0.58) GAAMTTPCHRM2ADRA2AADORA3
SCHEMBL593798 0.80 GAA (0.56) GAAMTTPCHRM2ADRA2AADORA3
Hydrochloric Acid SCHEMBL17729930 0.79 GAA (0.55) GAAMTTPCHRM2ADRA2AADORA3
SCHEMBL23418516 0.78 MTTP (0.65) GAAMTTPCHRM2ADRA2AADORA3
SCHEMBL7233050 0.77 MTTP (0.47) MTTPCHRM2ADRA2AADORA3CHRM1
SCHEMBL3726145 0.76 MTTP (0.54) GAAMTTPCHRM2ADRA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. 2010-06-24 — — US disclosed
US-7625948-B2 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2009-12-01 — — US disclosed
US-20050075367-A1 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-04-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075367-A1 Ester compound and medicinal use thereof LIPC, CES1, MTTP GAA 2055/4885MTTP 3/4885CHRM2 533/4885
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF LIPC, CES1, MTTP GAA 1962/4885MTTP 3/4885CHRM2 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback